Dr Reddy’s Laboratories (RDY) has released an update.
Dr. Reddy’s Laboratories Ltd. has announced that its wholly-owned subsidiary, Aurigene Oncology Limited, has invested Rs. 2,08,62,912 in Clean Renewable Energy KK 2A Private Limited (CREL), acquiring a 26.99% stake to support the development of a solar power project. The investment, which is not a related party transaction and is based on an independent valuation, aims to comply with Group Captive norms and bolster the company’s involvement in renewable energy.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.
